Robot surgery may cut complication rates in penile cancer treatment

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Patient has provided written informed consent. * 2\. Male patient ≥ 18 years at time of signing the informed consent form. * 3\. Patient has histologically proven penile squamous cell carcinoma. * 4\. Patient has indication for prophylactic (intermediate or high-risk primary tumor and cN0) or therapeutic (cN1/2) inguinal lymphadenectomy, i.e.: * pT1a, G2, cN0 OR * pT1b- pT3, any G, cN0 OR * pT1-pT3, any G, cN1-2 * 5\. Patients has adequate hepatic, renal and bone marrow function: * Hemoglobin ≥ 8.0 g/dL * Absolute neutrophil count ≥ 1.5 x 109 /L * Platelets ≥ 100 x 109 /L * International normalized ratio (INR) / activated partial thromboplastin time (aPTT) ≤ 1.5 × ULN unless participant is receiving anticoagulant therapy as long as PTT is within therapeutic range of intended use of anticoagulants. Anticoagulation is accepted according to the surgeon's practice. * 6\. Patient is willing and able to comply with the protocol for the duration of the study, including hospital visits for treatment and scheduled follow-up visits and examinations. * 7\. Performance status of the patient is judged by the treating physician as appropriate to undergo surgery. Exclusion Criteria: * 1\. Patients has inguinal bulky disease ≥ 4 cm (determined by ultrasound or cross-sectional imaging). * 2\. Patient has distant metastases. * 3\. Patient receives or is scheduled for neoadjuvant chemotherapy for PeCa. * 4\. Patient received previous major inguinal surgery (transabdominal laparoscopic inguinal hernia repair is permitted), lymph node resection or radiotherapy in the groin or pelvic area. * 5\. Patient participates in competing trials affecting the effects of the surgery or outcome measures. * 6\. Patient has addictive or other medical conditions that do not allow the subject to appreciate the nature and scope of the clinical trial and its potential consequences. * 7\. Patient has any co-existing medical condition that in the investigator's judgement will substantially increase the risk associated with the patient's participation in the study. * 8\. Patient has been incarcerated or involuntarily institutionalized by court order or by the authorities. * 9\. Patient is unable to consent because he does not understand the nature, significance and implications of the clinical trial and therefore cannot form a rational intention in the light of the facts.